EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy

Ragini D Singh, Avadhesh Avadhesh, Gaurav Sharma, Sagar Dholariya, Rima B Shah, Bela Goyal, Subash Chandra Gupta iD

Antioxidants & Redox Signaling · 2023

DOI: 10.1089/ars.2022.0116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, 2023. Verfasst von Ragini D Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences, Rajkot, India. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 243 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significance: Targeted cancer therapy with minimal off-target consequences has shown promise for some cancer types. Although cytochrome P450 (CYP) consists of 18 families, CYP1-4 families play key role in metabolizing xenobiotics and cancer drugs. This eventually affects the process of carcinogenesis, treatment outcomes, and cancer drug resistance. Differential overexpression of CYPs in transformed cells, together with phenotypic alterations in tumors, presents a potential for therapeutic intervention. Recent Advances: Recent advances in molecular tools and information technology have helped utilize CYPs as cancer targets. The precise expression in various tumors, X-ray crystal structures, improved understanding of the structure-activity relationship, and new approaches in the development of prodrugs have supported the ongoing efforts to develop CYP-based drugs with a better therapeutic index. Critical Issues: Narrow therapeutic index, off-target effects, drug resistance, and tumor heterogeneity limit the benefits of CYP-based conventional cancer therapies. In this review, we address the CYP1-4 families as druggable targets in cancer. An emphasis is given to the CYP expression, function, and the possible mechanisms that drive expression and activity in normal and transformed tissues. The strategies that inhibit or activate CYPs for therapeutic benefits are also discussed. Future Directions: Efforts are needed to develop more selective tools that will help comprehend molecular and metabolic alterations in tumor tissues with biological end-points in relation to CYPs. This will eventually translate to developing more specific CYP inhibitors/inducers. Antioxid. Redox Signal. 38, 853-876.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNeoplasmsXenobioticsCytochrome P-450 Enzyme SystemCell CommunicationOxidation-Reduction

Stichwörter der Autor:innen

cytochrome P450epoxygenasesorphan CYPprodrugω-hydroxylases

Substanzen

XenobioticsCytochrome P-450 Enzyme SystemProdrugs

Autor:innen und Institutionen

  • Department of Biochemistry, All India Institute of Medical Sciences, Rajkot, India.
  • Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
  • Department of Physiology, All India Institute of Medical Sciences, Rajkot, India.
  • Department of Pharmacology, All India Institute of Medical Sciences, Rajkot, India.
  • Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh, India.
  • Department of Biochemistry, All India Institute of Medical Sciences, Guwahati, India.

ORCID-Profile: Subash Chandra Gupta

Zitieren

APA

Singh, R. D., Avadhesh, A., Sharma, G., Dholariya, S., Shah, R. B., Goyal, B., & Gupta, S. C. (2023). Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2022.0116

Vancouver

Singh RD, Avadhesh A, Sharma G, Dholariya S, Shah RB, Goyal B, et al. Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy. Antioxidants & Redox Signaling. 2023. doi:10.1089/ars.2022.0116

BibTeX
@article{Singh2023,
  author = {Singh, Ragini D and Avadhesh, Avadhesh and Sharma, Gaurav and Dholariya, Sagar and Shah, Rima B and Goyal, Bela and Gupta, Subash Chandra},
  title = {Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy},
  journal = {Antioxidants & Redox Signaling},
  year = {2023},
  doi = {10.1089/ars.2022.0116}
}
Kostenlos starten →